{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:06:06Z","timestamp":1754161566631,"version":"3.41.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1023\/a:1023084520569","type":"journal-article","created":{"date-parts":[[2003,4,7]],"date-time":"2003-04-07T18:17:24Z","timestamp":1049739444000},"page":"1024-1026","source":"Crossref","is-referenced-by-count":1,"title":["CASE REPORT: Recurrent Mantle Cell Lymphoma After Allogeneic Bone Marrow Transplantation Presenting as Isolated Rectal Mass"],"prefix":"10.1007","volume":"48","author":[{"given":"Victor K.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishnu","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad A.","family":"Eloubeidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"465881_CR1","first-page":"3909","volume":"89","author":"The Non-Hodgkin's Lymphoma Classification Project; A clinical evaluation of the International Lymphoma Study Group","year":"1997","unstructured":"The Non-Hodgkin's Lymphoma Classification Project; A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: Blood 89:3909-3918, 1997","journal-title":"classification of non-Hodgkin's lymphoma: Blood"},{"key":"465881_CR2","first-page":"2658","volume-title":"Clinical Oncology, 2nd edn.","author":"TA Lister","year":"2000","unstructured":"Lister TA, Armitage JO: Non-Hodgkin's lymphomas. In Clinical Oncology, 2nd edn. MD Abeloff (ed). New York, Churchill Livingstone, 2000, pp 2658-2719","edition":"2nd edn."},{"key":"465881_CR3","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood.V83.10.2829.2829","volume":"83","author":"F Berger","year":"1994","unstructured":"Berger F, Felman P, Sonet A, Salles G, Bastion Y, Bryon PA, Coiffier B: Nonfollicular small B-cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome. Blood 83:2829-2835, 1994","journal-title":"Blood"},{"key":"465881_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood.V96.1.71","volume":"96","author":"IW Flinn","year":"2000","unstructured":"Flinn IW, Byrd JC, Morrison C, Jamison J, Diehl LF, Murphy T, Piantadosi S, Seifter E, Ambinder RF, Vogelsang G, Grever MR: Fludarabine and cyclophosphamide with filgrastim support in patients with previous untreated indolent lymphoid malignancies. Blood 96:71-75, 2000","journal-title":"Blood"},{"key":"465881_CR5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hon.2900070505","volume":"7","author":"P Meusers","year":"1989","unstructured":"Meusers P, Engelhard M, Bartels H, Binder T, Fulle HH, Gorg K, Gunzer U, Havemann K, Kayser W, Konig E: Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis. Hematol Oncol 7:365, 1989","journal-title":"Hematol Oncol"},{"key":"465881_CR6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.bmt.1702135","volume":"25","author":"D Decaudin","year":"2000","unstructured":"Decaudin D, Brousse N, Brice P, Haioun C, Bourhis JH, Morel P, Van Hoof A, Souleau B, Quesnel B, Gisselbrecht C: Efficacy of autologous stem cell transplantation in mantle cell lymphoma, a 3-year follow-up study. Bone Marrow Transplant 25:251-256, 2000","journal-title":"Bone Marrow Transplant"},{"key":"465881_CR7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1083-8791(00)70030-9","volume":"6","author":"JM Vose","year":"2000","unstructured":"Vose JM, Bierman PJ, Weisenburger DD, Lynch JC, Bociek Y, Chan WC, Greiner TC, Armitage JO: Autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant 6:640-645, 2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"465881_CR8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1702567","volume":"26","author":"C Mart\u00ednez","year":"2000","unstructured":"Mart\u00ednez C, Carreras E, Rovira M, Urbano-Ispizua A, Esteve J, Fernandez-Aviles F, Perales M, Rives S, Gomez M, Montserrat E: Patients with mantle-cell lymphoma relapsing after autologous stem cell transplantation may be rescued by allogeneic transplantation. Bone Marrow Transplant 26:677-679, 2000","journal-title":"Bone Marrow Transplant"},{"key":"465881_CR9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0016-5085(97)70212-9","volume":"112","author":"A Ruskon\u00e9-Fourmestraux","year":"1997","unstructured":"Ruskon\u00e9-Fourmestraux A, Delmer A, Lavergne, Molina T, Brousse N, Audouin J, Rambaud JC: Multiple lymphomatous polyposis of the gastrointestinal tract, prospective clinicopathologic study of 31 cases. Groupe D'\u00e9tude des Lymphomes Digestifs. Gastroenterology 112:7-26, 1997","journal-title":"Gastroenterology"},{"key":"465881_CR10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2559.2000.00813.x","volume":"36","author":"P Watson","year":"2000","unstructured":"Watson P, Wood KM, Lodge A, McIntosh GG, Milton I, Piggott NH, Proctor SJ, Taylor PR, Smith S, Jack F, Bell H, Steward M, Anderson JJ, Home CH, Angus B: Monoclonal antibodies recognizing CD5, CD11, and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in diagnosis of small B-cell lymphoma. Histopathology 36:145-150, 2000","journal-title":"Histopathology"},{"key":"465881_CR11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00001622-200109000-00005","volume":"13","author":"JP Leonard","year":"2001","unstructured":"Leonard JP, Schattner EJ, Coleman M: Biology and management of mantle cell lymphoma. Curr Opin Oncol 13:342-347, 2001","journal-title":"Curr Opin Oncol"},{"key":"465881_CR12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/1096-8652(200007)64:3<190::AID-AJH9>3.0.CO;2-B","volume":"64","author":"DD Weisenburger","year":"2000","unstructured":"Weisenburger DD, Vose JM, Greiner TC, Lynch JC, Chan WC, Bierman PJ, Dave BJ, Sanger WG, Armitage JO: Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol 64:190-196, 2000","journal-title":"Am J Hematol"},{"key":"465881_CR13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.2000.18.2.317","volume":"18","author":"JM Foran","year":"2000","unstructured":"Foran JM, Rohatiner AZ, Cunningham D, Popescu PR, Solal-Celigny P, Ghielmini M, Coiffier B, Johnson PW, Gisselbrecht, Reyes F, Radford JA, Bessel EM, Souleau B, Benzohra A, Lister TA: European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. J Clin Oncol 18:317-324, 2000","journal-title":"J Clin Oncol"},{"key":"465881_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1008309405678","volume":"11","author":"JM Foran","year":"2000","unstructured":"Foran JM, Cunningham D, Coiffier B, Solal-Celigny P, Reyes F, Ghielmini M, Johnson PW, Gisselbrecht C, Bradbum M, Matthews J, Lister TA: Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response. Ann, Oncol 11:117-121, 2000","journal-title":"Ann, Oncol"},{"key":"465881_CR15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1008301432453","volume":"11","author":"M Ghielmini","year":"2000","unstructured":"Ghielmini M, Schmitz SF, Burki K, Pichert G, Betticher DC, Stupp R, Wemli M, Lohri A, Schmitter D, Bertoni F, Cemy T: The effects of rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 11:123-126, 2000","journal-title":"Ann Oncol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1023084520569.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1023084520569\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1023084520569.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T02:40:15Z","timestamp":1753756815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1023084520569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["465881"],"URL":"https:\/\/doi.org\/10.1023\/a:1023084520569","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}